• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus.

作者信息

Laun Sarah E, Kann Lisa, Braun Jerome, Gilbert Stacey, Lunz Daniel, Pierre Francia, Kalra Andrew, Ma Ke, Tsai Hua-Ling, Wang Hao, Jit Simran, Cheng Yulan, Ahmed Yousra, Wang Kenneth K, Leggett Cadman L, Cellini Ashley, Ioffe Olga B, Zaidi Ali H, Omstead Ashten N, Jobe Blair, Korman Louis, Cornish Drew, Zellenrath Pauline, Spaander Manon, Kuipers Ernst, Perpetua Lorrie, Greenwald Bruce D, Maddala Tara, Meltzer Stephen J

机构信息

Previse, Baltimore, Maryland, USA.

Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003030.

DOI:10.14309/ajg.0000000000003030
PMID:39140473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11825890/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/9ee96d17a704/acg-120-1296-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/57eb129312ac/acg-120-1296-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/ce9a6f7ad7d6/acg-120-1296-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/c968dcb9dc92/acg-120-1296-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/8d56bb63b500/acg-120-1296-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/edb53ea70a3c/acg-120-1296-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/9ee96d17a704/acg-120-1296-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/57eb129312ac/acg-120-1296-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/ce9a6f7ad7d6/acg-120-1296-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/c968dcb9dc92/acg-120-1296-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/8d56bb63b500/acg-120-1296-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/edb53ea70a3c/acg-120-1296-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b69/12124208/9ee96d17a704/acg-120-1296-g008.jpg

相似文献

1
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus.一种用于对巴雷特食管患者进行准确风险分层的表观遗传学预后检测方法的验证
Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003030.
2
Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus.巴雷特食管患者中基于风险分层的表观遗传生物标志物检测的时空研究
Am J Gastroenterol. 2025 Feb 12;120(6):1285-1295. doi: 10.14309/ajg.0000000000003367.
3
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类：一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
4
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果：面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
5
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统，50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
6
CALCULATION OF TOTAL ENERGY EXPENDITURE IN ADULTS WITH CROHN'S DISEASE BY INDIRECT CALORIMETRY AND SIMPLE WEIGHT-BASED EQUATIONS: A COMPARATIVE STUDY.通过间接测热法和基于体重的简单公式计算克罗恩病成年患者的总能量消耗：一项对比研究
Arq Gastroenterol. 2025 Jun 16;62:e24122. doi: 10.1590/S0004-2803.24612024-122. eCollection 2025.
7
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
8
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较：一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
9
Age distribution and risk factors for Barrett's esophagus by sex at health check-up settings in Japan.日本健康检查机构中按性别划分的巴雷特食管的年龄分布及危险因素
J Gastroenterol. 2025 Feb 10. doi: 10.1007/s00535-025-02222-2.
10
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease.一年的练习效果可预测帕金森病的长期认知结果。
J Parkinsons Dis. 2025 Apr 29:1877718X251339585. doi: 10.1177/1877718X251339585.

引用本文的文献

1
DNA methylation in esophageal cancer: technological advances and early detection clinical applications.食管癌中的DNA甲基化：技术进展与早期检测的临床应用
Front Oncol. 2025 Jul 11;15:1543190. doi: 10.3389/fonc.2025.1543190. eCollection 2025.
2
Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus.巴雷特食管患者中基于风险分层的表观遗传生物标志物检测的时空研究
Am J Gastroenterol. 2025 Feb 12;120(6):1285-1295. doi: 10.14309/ajg.0000000000003367.
3
Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.

本文引用的文献

1
Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.巴雷特食管的诊断和管理：欧洲胃肠道内镜学会（ESGE）指南。
Endoscopy. 2023 Dec;55(12):1124-1146. doi: 10.1055/a-2176-2440. Epub 2023 Oct 9.
2
Predicting Incident Adenocarcinoma of the Esophagus or Gastric Cardia Using Machine Learning of Electronic Health Records.基于电子健康记录的机器学习预测食管或胃贲门部腺癌。
Gastroenterology. 2023 Dec;165(6):1420-1429.e10. doi: 10.1053/j.gastro.2023.08.011. Epub 2023 Aug 18.
3
Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study.
巴雷特食管患者的表观遗传预后检测方法Esopredict的分析验证
Diagnostics (Basel). 2024 Sep 10;14(18):2003. doi: 10.3390/diagnostics14182003.
4
The Role of DNA Methylation in Gastrointestinal Disease: An Expanded Review of Malignant and Nonmalignant Gastrointestinal Diseases.DNA甲基化在胃肠道疾病中的作用：对恶性和非恶性胃肠道疾病的扩展综述
Gastroenterology. 2025 Feb;168(2):245-266. doi: 10.1053/j.gastro.2024.07.001. Epub 2024 Jul 4.
基于人群队列研究的内镜后食管腺癌和内镜后食管肿瘤的幅度和时间趋势：北欧 Barrett 食管研究。
Gastroenterology. 2023 Oct;165(4):909-919.e13. doi: 10.1053/j.gastro.2023.05.044. Epub 2023 Jun 4.
4
Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett's Esophagus, and Barrett's Esophagus-Related Neoplasia in the United States.美国胃食管反流病、巴雷特食管及巴雷特食管相关肿瘤患者的医疗资源利用情况及费用
J Health Econ Outcomes Res. 2023 Mar 3;10(1):51-58. doi: 10.36469/001c.68191. eCollection 2023.
5
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
6
Clinical variation in surveillance and management of Barrett's esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons.巴雷特食管监测和管理的临床差异：对胃肠病学家和胃肠外科医生的横断面研究。
Medicine (Baltimore). 2022 Dec 23;101(51):e32187. doi: 10.1097/MD.0000000000032187.
7
The utility of a genetic progression risk test for Barrett esophagus.巴雷特食管遗传进展风险检测的效用。
Medicine (Baltimore). 2022 Sep 16;101(37):e30503. doi: 10.1097/MD.0000000000030503.
8
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Barrett 食管的诊断和管理：ACG 指南更新。
Am J Gastroenterol. 2022 Apr 1;117(4):559-587. doi: 10.14309/ajg.0000000000001680.
9
Progression of Barrett's esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis.三维计算机辅助分析的广域上皮内取样诊断的 Barrett 食管、隐窝发育不良和低级别上皮内瘤变的进展：一项回顾性分析。
Gastrointest Endosc. 2022 Mar;95(3):410-418.e1. doi: 10.1016/j.gie.2021.09.014. Epub 2021 Sep 16.
10
Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction.预测食管或食管胃交界腺癌发病工具的验证
Am J Gastroenterol. 2021 May 1;116(5):949-957. doi: 10.14309/ajg.0000000000001255.